Text size: AAA

Search Form

High Cost Drugs exc. from tariff

A number of high cost drugs, devices, procedures and products have been excluded from the scope of the national tariff of payment by results . Following the re-organisation of the NHS these drugs are commissioned by:

  • NHS England or
  • the Clinical Commissioning Groups

For a detailed list of the NHS National Tariff Payment System for 2019 to 2020 see here

For a detailed list of medicines not reimbursed through the national prices and directly commissioned by NHS England click here - (Version 14 Published April 2019)

NHS England are the responsible commissioners for the management of the Cancer Drugs Fund. For details of the CDF click here

For a list of technologies with approved Patient Access Schemes click here

The Manual - this is a technical document describing the prescribed specialised services, some of these are directly commissioned by NHS England and some by CCGs

Commissioning intentions - this serves as notice to all providers of specialised services in England of changes and priorities for the coming year

Gain Sharing - principles for sharing the benefits associated with more efficient use of medicines not reimbursed through national tariff prices

A significant proportion of high cost drugs excluded from tariff are commissioned by Derbyshire in line with NICE Technology Appraisals.  Biologic algorithms for use in Rheumatology, Gastroenterology and Dermatology are listed below:


Atopic Dermatitis (last updated October 2018)

Psoriasis (last updated March 2019)
- Prior Approval Form for completion if switching


Crohn's Disease (last updated March 2019)

Ulcerative Colitis (last updated March 2019)


Age-Related Macular Degeneration (ARMD) (last updated January 2018)

Macular Oedema due to BRVO/CRVO (last updated January 2018)

Diabetic Macular Oedema (DMO) (last updated January 2018)

Non-Infectious Posterior Uveitis  (last updated January 2018)


Rheumatoid Arthritis (commissioning variations of NICE TAs) (last updated March 2019)

Ankylosing Spondylitis (last updated March 2019)

Psoriatic Arthritis (last updated March 2019)